Coat's disease
ICD-10 H35.0 ICD-11 LD21.Y

Coats' Disease at Shields Stage 1–2 with Progression After Laser Photocoagulation

This protocol addresses Coats' disease presenting at Shields stage 1 (retinal telangiectasia only) or stage 2 (telangiectasia with exudation) where the disease has continued to progress despite initial treatment.

Clinical scenario

The patient has mild Coats' disease — either telangiectasia alone (stage 1) or telangiectasia with subretinal exudation (stage 2) — and the condition is documented to be progressing. The clinical priority is to arrest this progression and achieve resolution of the exudative process before more advanced stages develop.

Previous treatment — goal not achieved

Laser photocoagulation (argon laser) was applied as the primary treatment to cauterise the abnormal retinal vasculature. The intended endpoint — ablation and regression of that abnormal vasculature — was not reached. The current protocol represents the next step when laser photocoagulation is not possible or has proven insufficient.

Next-line approach (partial overview)

When laser cannot adequately reach the abnormal vessels — particularly in the presence of thick subretinal exudation — a cold-based ablative technique is employed as an alternative. Treatment is staged carefully, targeting a limited area at a time, with a defined interval between sessions. Multiple sessions may be necessary.

Full sequence, session parameters, and escalation criteria are in the complete protocol ↓

Treatment goals

Resolution of exudative disease and prevention of retinal detachment.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1159/000336906

  • Retinal telangiectasia only
  • Telangiectasia and exudation
  • Mild disease (1, 2) Laser photocoagulation/cryotherapy
  • If thick exudation is present, laser treatment may not be particularly useful, as it may not be able to reach the vessels, and cryotherapy is preferred.
  • Cryotherapy is used in Coat's disease especially in patients presenting with exudative disease and retinal detachment, which corresponds to stages 1–3b of Shields' classification.
  • When laser photocoagulation is not possible, even being the treatment of choice for mild Coat's disease, cryotherapy is utilized and believed to be more effective than laser in more advanced cases.
  • Like laser photocoagulation, it may require multiple sessions, although if excessive it may conversely lead to an increase in subretinal exudation and an increase in retinal detachment.
  • Therefore, it is advisable to use it for only up to two quadrants at a time, with a month gap between treatments.
View source ↗